These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27050560)

  • 1. Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.
    Zhang J; Wang P; Ji W; Ding Y; Lu X
    Int J Neurosci; 2017 Mar; 127(3):210-217. PubMed ID: 27050560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
    Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
    J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
    Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
    J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
    Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of microRNA-134 correlates with malignancy and poor prognosis in human glioma.
    Zhong J; Li B
    J Clin Neurosci; 2015 Mar; 22(3):583-7. PubMed ID: 25564273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen-G overexpression predicts poor clinical outcomes in low-grade gliomas.
    Fan X; Wang Y; Zhang C; Liu X; Qian Z; Jiang T
    J Neuroimmunol; 2016 May; 294():27-31. PubMed ID: 27138095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
    Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
    Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
    Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
    Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
    J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.
    Wang L; Wu L; Wu J
    J Int Med Res; 2016 Oct; 44(5):994-1001. PubMed ID: 27417886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
    Ding D; Song T; Jun W; Tan Z; Fang J
    Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
    Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
    Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma.
    Sibin MK; Bhat DI; Narasingarao KV; Lavanya Ch; Chetan GK
    Tumour Biol; 2015 Sep; 36(10):7607-14. PubMed ID: 25921285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.
    Coppola D; Balducci L; Chen DT; Loboda A; Nebozhyn M; Staller A; Fulp WJ; Dalton W; Yeatman T; Brem S
    J Geriatr Oncol; 2014 Oct; 5(4):389-99. PubMed ID: 25220188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
    Chen T; Wang XY; Li C; Xu SJ
    Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.